Skip to main content
Clarence Creech II, MD, Pediatric Infectious Disease, Nashville, TN, Vanderbilt University Medical Center

ClarenceBCreechIIMDMPH

Pediatric Infectious Disease Nashville, TN

Associate Professor of Pediatrics, Vanderbilt University School of Medicine; Director, Vanderbilt Vaccine Research Program

Dr. Creech is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Creech's full profile

Already have an account?

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Pediatric Infectious Diseases, 2003 - 2006
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Pediatrics, 1999 - 2002
  • University of Tennessee Health Science Center College of Medicine
    University of Tennessee Health Science Center College of MedicineClass of 1999

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2002 - 2025
  • FL State Medical License
    FL State Medical License 2019 - 2021
  • AL State Medical License
    AL State Medical License 2020 - 2020
  • American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

  • PIDS Young Investigator Award PIDS, 2012
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Policy Recommendations for Optimizing the Infectious Diseases Physician-Scientist Workforce  
    Wendy Armstrong, Ebbing Lautenbach, Kyle J Popovich, C Buddy Creech, Roger Bedimo, Upinder Singh, Jatin M Vyas, The Journal of Infectious Diseases

Press Mentions

  • RSV Surge in Children Likely Caused by ‘Immunity Gap,’ Not COVID-19 Vaccine
    RSV Surge in Children Likely Caused by ‘Immunity Gap,’ Not COVID-19 VaccineNovember 18th, 2022
  • VUMC Selected to Recruit up to 1,000 Participants for Pivotal Phase 3 Moderna Vaccine Clinical Trial
    VUMC Selected to Recruit up to 1,000 Participants for Pivotal Phase 3 Moderna Vaccine Clinical TrialJuly 16th, 2020
  • FDA Delays Decision on Vaccines for Children Under 5
    FDA Delays Decision on Vaccines for Children Under 5February 12th, 2022

Hospital Affiliations